Health-related quality of life in children with congenital heart disease aged 5 to 7 years: a multicentre controlled cross-sectional study.


Journal

Health and quality of life outcomes
ISSN: 1477-7525
Titre abrégé: Health Qual Life Outcomes
Pays: England
ID NLM: 101153626

Informations de publication

Date de publication:
12 Nov 2020
Historique:
received: 27 07 2020
accepted: 30 10 2020
entrez: 13 11 2020
pubmed: 14 11 2020
medline: 30 3 2021
Statut: epublish

Résumé

In the context of tremendous progress in congenital cardiology, more attention has been given to patient-related outcomes, especially in assessing health-related quality of life (HRQoL) of patients with congenital heart diseases (CHD). However, most studies have mainly focused on teenagers or adults and currently, few HRQoL controlled data is available in young children. This study aimed to evaluate HRQoL of children with CHD aged 5 to 7 y.o., in comparison with contemporary peers recruited in school, as well as the factors associated with HRQoL in this population. This multicentre controlled prospective cross-sectional study included 124 children with a CHD (mean age = 6.0 ± 0.8 y, 45% female) during their outpatient visit and 125 controls (mean age = 6.2 ± 0.8 y, 54% female) recruited at school. A generic paediatric HRQoL instrument was used (PedsQL 4.0). Self-reported HRQoL in children with CHD was similar to controls, overall (73.5 ± 1.2 vs. 72.8 ± 1.2, P = 0.7, respectively), and for each dimension. Parents-reported HRQoL was significantly lower in the CHD group than in controls. HRQoL was predicted by the disease severity and by repeated invasive cardiac procedures (surgery or catheterization). HRQoL in young children with CHD aged 5 to 7 years old was good and similar to controls. This study contributed to the growing body of knowledge on HRQoL in congenital cardiology and emphasized the need for child and family support in the most complex CHD. Trial registration This study was approved by the institutional review board of Montpellier University Hospital (2019_IRB-MTP_02-19) on 22 February 2019 and was registered on ClinicalTrials.gov (NCT03931096) on 30 April 2019, https://clinicaltrials.gov/ct2/show/NCT03931096 .

Sections du résumé

BACKGROUND BACKGROUND
In the context of tremendous progress in congenital cardiology, more attention has been given to patient-related outcomes, especially in assessing health-related quality of life (HRQoL) of patients with congenital heart diseases (CHD). However, most studies have mainly focused on teenagers or adults and currently, few HRQoL controlled data is available in young children. This study aimed to evaluate HRQoL of children with CHD aged 5 to 7 y.o., in comparison with contemporary peers recruited in school, as well as the factors associated with HRQoL in this population.
METHODS METHODS
This multicentre controlled prospective cross-sectional study included 124 children with a CHD (mean age = 6.0 ± 0.8 y, 45% female) during their outpatient visit and 125 controls (mean age = 6.2 ± 0.8 y, 54% female) recruited at school. A generic paediatric HRQoL instrument was used (PedsQL 4.0).
RESULTS RESULTS
Self-reported HRQoL in children with CHD was similar to controls, overall (73.5 ± 1.2 vs. 72.8 ± 1.2, P = 0.7, respectively), and for each dimension. Parents-reported HRQoL was significantly lower in the CHD group than in controls. HRQoL was predicted by the disease severity and by repeated invasive cardiac procedures (surgery or catheterization).
CONCLUSION CONCLUSIONS
HRQoL in young children with CHD aged 5 to 7 years old was good and similar to controls. This study contributed to the growing body of knowledge on HRQoL in congenital cardiology and emphasized the need for child and family support in the most complex CHD. Trial registration This study was approved by the institutional review board of Montpellier University Hospital (2019_IRB-MTP_02-19) on 22 February 2019 and was registered on ClinicalTrials.gov (NCT03931096) on 30 April 2019, https://clinicaltrials.gov/ct2/show/NCT03931096 .

Identifiants

pubmed: 33183312
doi: 10.1186/s12955-020-01615-6
pii: 10.1186/s12955-020-01615-6
pmc: PMC7659069
doi:

Banques de données

ClinicalTrials.gov
['NCT03931096']

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

366

Références

Patient Educ Couns. 2014 Apr;95(1):137-42
pubmed: 24462120
Cardiol Young. 2018 Feb;28(2):192-198
pubmed: 28889827
Pediatr Cardiol. 2007 Jul-Aug;28(4):255-62
pubmed: 17486393
Nurs Clin North Am. 2004 Dec;39(4):727-40
pubmed: 15561156
Congenit Heart Dis. 2019 Sep;14(5):778-784
pubmed: 31066183
J Clin Epidemiol. 1993 Dec;46(12):1417-32
pubmed: 8263569
Arch Dis Child. 2019 Feb;104(2):124-128
pubmed: 29599167
Pediatrics. 2008 May;121(5):e1060-7
pubmed: 18450848
Patient Educ Couns. 2019 Dec;102(12):2223-2230
pubmed: 31262673
Adv Biomed Res. 2015 Nov 30;4:255
pubmed: 26918237
Int J Cardiol. 2019 May 15;283:112-118
pubmed: 30616811
Int J Cardiol. 2016 Jan 15;203:1052-60
pubmed: 26638054
J Am Coll Cardiol. 2018 May 29;71(21):2434-2446
pubmed: 29793633
Int J Cardiol. 2019 Jun 15;285:86-92
pubmed: 30857849
Med Care. 2001 Aug;39(8):800-12
pubmed: 11468499
Heart. 2005 Sep;91(9):1193-8
pubmed: 16103557
J Jpn Phys Ther Assoc. 2005;8(1):39-45
pubmed: 25792942
J Pediatr Psychol. 2012 Nov-Dec;37(10):1089-103
pubmed: 22976507
J Thorac Dis. 2016 Dec;8(12):E1632-E1636
pubmed: 28149600
J Pediatr Endocrinol Metab. 2017 Aug 28;30(8):863-868
pubmed: 28753541
Orphanet J Rare Dis. 2011 Oct 03;6:64
pubmed: 21968022
Pediatr Cardiol. 2015 Dec;36(8):1588-601
pubmed: 26024647
Arch Dis Child. 2019 Apr;104(4):340-347
pubmed: 29572215
Health Serv Insights. 2014 Feb 10;7:1-12
pubmed: 25114568
Pediatr Cardiol. 2008 Mar;29(2):409-15
pubmed: 18026777
Pediatr Cardiol. 2014 Oct;35(7):1174-80
pubmed: 24801674
Med Care. 1999 Feb;37(2):126-39
pubmed: 10024117
Eur Heart J Qual Care Clin Outcomes. 2018 Jan 1;4(1):51-58
pubmed: 28950356
Eur J Pediatr. 2010 Mar;169(3):333-47
pubmed: 19768468
Pediatr Cardiol. 1992 Apr;13(2):72-5
pubmed: 1614922
BMJ Paediatr Open. 2019 Apr 3;3(1):e000377
pubmed: 31206069
Heart. 2000 Jun;83(6):685-7
pubmed: 10814630
Int J Cardiol. 2008 Mar 28;125(1):66-73
pubmed: 17433472
Cardiol Young. 2018 Jan;28(1):21-26
pubmed: 28847316
Cardiol Young. 2016 Oct;26(7):1250-9
pubmed: 26980152
J Cardiovasc Nurs. 2012 Nov-Dec;27(6):539-46
pubmed: 21912272
Circulation. 2012 Aug 28;126(9):1143-72
pubmed: 22851541
Pediatrics. 2014 Oct;134(4):e1129-48
pubmed: 25246620
Arch Dis Child. 2018 Feb;103(2):170-175
pubmed: 28855227
Eur J Cardiothorac Surg. 2013 Jun;43(6):1096-100
pubmed: 23345176
J Am Coll Cardiol. 2001 Apr;37(5):1170-5
pubmed: 11300418
Eur J Prev Cardiol. 2014 Aug;21(8):949-55
pubmed: 23460658
Ambul Pediatr. 2003 Nov-Dec;3(6):329-41
pubmed: 14616041
Arch Cardiovasc Dis. 2018 Mar;111(3):180-188
pubmed: 29100908
Cardiol Young. 2006 Apr;16(2):165-72
pubmed: 16553979
MCN Am J Matern Child Nurs. 2015 Jan-Feb;40(1):16-23; quiz E3-4
pubmed: 25330332
J Pediatr. 2014 Apr;164(4):781-788.e1
pubmed: 24412135
Annu Rev Clin Psychol. 2012;8:455-80
pubmed: 22224836
Eur J Cardiovasc Prev Rehabil. 2005 Oct;12(5):498-502
pubmed: 16210938
Heart. 2018 Jun;104(12):1026-1036
pubmed: 29170358
Eur J Cardiovasc Nurs. 2013 Oct;12(5):475-83
pubmed: 23406676

Auteurs

Hamouda Abassi (H)

Paediatric and Congenital Cardiology Department, Arnaud De Villeneuve University Hospital, 371 Avenue du Doyen Giraud, 34295, Montpellier, France.
Centre for Studies and Research On Health Services and Quality of Life, Public Health and Chronic Diseases Laboratory, Aix Marseille University, Marseille, France.
PhyMedExp, CNRS, INSERM, University of Montpellier, Montpellier, France.

Helena Huguet (H)

Epidemiology Department, University Hospital, Clinical Investigation Centre, INSERM-CIC 1411, University of Montpellier, Montpellier, France.

Marie-Christine Picot (MC)

Epidemiology Department, University Hospital, Clinical Investigation Centre, INSERM-CIC 1411, University of Montpellier, Montpellier, France.

Marie Vincenti (M)

Paediatric and Congenital Cardiology Department, Arnaud De Villeneuve University Hospital, 371 Avenue du Doyen Giraud, 34295, Montpellier, France.
PhyMedExp, CNRS, INSERM, University of Montpellier, Montpellier, France.

Sophie Guillaumont (S)

Paediatric and Congenital Cardiology Department, Arnaud De Villeneuve University Hospital, 371 Avenue du Doyen Giraud, 34295, Montpellier, France.
Paediatric Cardiology and Rehabilitation Unit, St-Pierre Institute, Palavas-Les-Flots, France.

Annie Auer (A)

Paediatric Cardiology and Rehabilitation Unit, St-Pierre Institute, Palavas-Les-Flots, France.

Oscar Werner (O)

Paediatric and Congenital Cardiology Department, Arnaud De Villeneuve University Hospital, 371 Avenue du Doyen Giraud, 34295, Montpellier, France.
Paediatric Cardiology and Rehabilitation Unit, St-Pierre Institute, Palavas-Les-Flots, France.

Gregoire De La Villeon (G)

Paediatric and Congenital Cardiology Department, Arnaud De Villeneuve University Hospital, 371 Avenue du Doyen Giraud, 34295, Montpellier, France.
Paediatric Cardiology and Rehabilitation Unit, St-Pierre Institute, Palavas-Les-Flots, France.

Kathleen Lavastre (K)

Paediatric and Congenital Cardiology Department, Arnaud De Villeneuve University Hospital, 371 Avenue du Doyen Giraud, 34295, Montpellier, France.

Arthur Gavotto (A)

Paediatric and Congenital Cardiology Department, Arnaud De Villeneuve University Hospital, 371 Avenue du Doyen Giraud, 34295, Montpellier, France.
PhyMedExp, CNRS, INSERM, University of Montpellier, Montpellier, France.

Pascal Auquier (P)

Centre for Studies and Research On Health Services and Quality of Life, Public Health and Chronic Diseases Laboratory, Aix Marseille University, Marseille, France.

Pascal Amedro (P)

Paediatric and Congenital Cardiology Department, Arnaud De Villeneuve University Hospital, 371 Avenue du Doyen Giraud, 34295, Montpellier, France. p-amedro@chu-montpellier.fr.
Centre for Studies and Research On Health Services and Quality of Life, Public Health and Chronic Diseases Laboratory, Aix Marseille University, Marseille, France. p-amedro@chu-montpellier.fr.
PhyMedExp, CNRS, INSERM, University of Montpellier, Montpellier, France. p-amedro@chu-montpellier.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH